Please enter the email address you registered with to access the event.
Presenters
Dr. Ken Tamama
Professor of Pathology, Medical Director, Clinical Toxicology Laboratory
University of Pittsburgh School of Medicine, USA
Dr. Ken Tamama is the Medical Director of the Clinical Toxicology Laboratory and Clinical Pathology Informatics. He is also Director of Pathology Resident Training in Clinical Chemistry. He is a board-certified clinical pathologist with expertise in assay development of newly emerging drugs of abuse, toxicology test optimization, and various approaches to drug screening using mass spectrometry and other testing modalities.
Dr. Rahiwa Gebre
Neurologist, Assistant Professor of Neurology, Department of Neurology
University of Pittsburgh School of Medicine, USA
Dr. Rahiwa Gebre specializes in epilepsy neurology and is board-certified in neurology by the American Board of Psychiatry and Neurology. Dr. Gebre received her medical degree from Yale University School of Medicine and completed her residency and fellowship at Yale University School of Medicine and Yale New Haven Hospital. Her research interests focus on anti-epileptic drug monitoring during pregnancy and post-partum lactation.
Sarah Thomas
Associate Editor
SelectScience